Transcriptic
Strateos (formerly Transcriptic) operates a Cloud Lab Automation-as-a-Service Platform that lets pharmaceutical, biotechnology, academic, and AI drug discovery customers design, run, and analyze life sciences experiments remotely on cloud-connected robotic laboratories via web browser.
- Company typePrivate
- Founded2012
- HeadquartersMenlo Park, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Transcriptic does
Strateos, Inc. (formerly Transcriptic) operates what it describes as the world's first R&D Cloud Automation Platform for life sciences, providing cloud-connected robotic laboratories accessible to scientists via a web browser. Founded in 2016 as Transcriptic, the company merged with 3Scan in 2019 and rebranded to Strateos, combining robotic cloud lab capabilities with tissue imaging technology. The platform offers three primary service tiers: remote access to Strateos-operated cloud labs (Control Our Lab), software for customers to control their own instruments (Control Your Lab), and lab design-build services (Build Your Lab), supported by additional solutions in AI for Drug Discovery, Antibody Discovery, Discovery Biology, Small Molecule Drug Discovery, Chemistry, Synthetic Biology, Tissue Technology, and High Content Imaging.
The platform integrates high-throughput lab automation with cloud-connected robotics, an in-house lab control software stack, and the Autoprotocol open-source experiment-description standard. Core technical components include the browser-based experiment design interface, a login portal at secure.strateos.com, and a developer portal at developers.strateos.com. The company operates two physical lab facilities in San Diego and Menlo Park and serves pharmaceutical companies, biotechnology firms (from early-stage startups to established players), contract research organizations, academic institutions, and AI-driven drug discovery companies.
Strateos generates revenue through subscription-based access to its cloud lab platform, software licensing for its lab control software, and professional services for lab design and build projects. Go-to-market combines enterprise field sales targeting pharma and biotech accounts, event-driven demand generation (including its own annual Cloud Lab, HTE, & Lab Automation Virtual Conference), and product-led growth through self-service web-based experiment access. Pricing is quote-based with no publicly disclosed tiers. As of March 2021, the company had raised $56 million in Series B funding.
Transcriptic firmographics
Firmographics- Name
- Transcriptic
- Legal name
- Strateos, Inc.
- Website
- https://transcriptic.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Strateos (formerly Transcriptic) operates a Cloud Lab Automation-as-a-Service Platform that lets pharmaceutical, biotechnology, academic, and AI drug discovery customers design, run, and analyze life sciences experiments remotely on cloud-connected robotic laboratories via web browser.
- Ownership category
- akta.pro rank
Transcriptic industry classification
Industry- Product category
- Cloud Lab Automation Platform
- NAICS
- Software Publishers (513210), Computer Systems Design and Related Services (5415), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370), Industrial Instruments For Measurement, Display, And Control (3823)
- akta.pro primary industry
- Lab Automation, Instrument Control & Workflow Orchestration Software (HLAGAJAG)
- akta.pro secondary industries
- Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations) (HLAGAIAD), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), iBPMS (Intelligent BPM Suites) & Process Automation Suites (HDAEAHAG)
Keywords
Where Transcriptic is headquartered
LocationHeadquarters
- HQ city
- Menlo Park
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Transcriptic business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Infrastructure, Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- Cloud Lab Automation-as-a-Service: Subscription-based access to remote-controlled robotic laboratories. Scientists access the cloud lab via web browser to run experiments. Model combines recurring subscription elements with usage-based components based on experiment volume and complexity.
- Lab Build Services: Smart lab facility design-build services and lab control software implementation for organizations wanting to control their own facilities. One-time professional services and implementation revenue.
- Software Licensing: Lab control software deployed to customer facilities for remote instrument control, workflow scheduling, and data management.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Quote-based enterprise pricing |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels7 records
Transcriptic product offering
Product offeringCore offering
Strateos (formerly Transcriptic) operates a Cloud Lab Automation-as-a-Service Platform that lets scientists design, run, and analyze life sciences experiments remotely through a web browser by combining cloud-connected robotic laboratory equipment with intelligent lab control software and high-throughput experimentation. The company also provides Lab Build design-build services and on-premises Lab Control Software for organizations wanting to operate their own cloud-connected robotic facilities, alongside specialized drug discovery, synthetic biology, chemistry, and imaging solutions.
Product overview
Strateos (formerly Transcriptic) operates a Cloud Lab Automation-as-a-Service Platform as its core offering, reimagining the laboratory as a smart data generation center. The platform provides three primary service tiers: 'Control Our Lab' for accessing Strateos-operated remote automated cloud laboratories via web browser, 'Control Your Lab' for organizations to control their own scientific instruments and facilities using design-build services and lab control software, and 'Build Your Lab' for smart lab facility construction. Specialized drug discovery solutions include AI for Drug Discovery, Antibody Discovery, Discovery Biology, Small Molecule Drug Discovery (with sub-services for assay development, automation, chemical libraries, hit identification, and lead optimization), Chemistry, Synthetic Biology, Tissue Technology, and High Content Imaging. Additional capabilities include Auto-DMTA for automated design-make-test-analyze loops and Virtual Tour access to facilities in San Diego and Menlo Park.
Differentiator
Problem solved
Functional benefit
Products and services
- Strateos Cloud Lab (Cloud Lab Automation-as-a-Service Platform)
- Control Your Lab
- Build Your Lab
- AI for Drug Discovery
- Antibody Discovery
- Discovery Biology
- Small Molecule Drug Discovery
- Chemistry (Medicinal Chemistry)
Quantifiable outcome
- Significant decrease in hands-on scientist time through automated experiment execution
- +1 more outcomes
Companies that use Transcriptic
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles4 records
Transcriptic technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Transcriptic partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Strateos Small Molecule Discovery PartnershipcoreLaunch of Rapid Idea-to-Data Solution for Small Molecule Discovery on Strateos' Cloud Lab Automation-as-a-Service Platform, enabling accelerated drug discovery workflows from hit identification through lead optimization.
Scale indicators1 record
Recent moves6 records
Expansion highlights6 records
Transcriptic competitors and assessment
Company assessmentDirect peers
- Emerald Cloud Lab: Emerald Cloud Lab operates a remote-controlled, cloud-accessible life sciences laboratory similar to Strateos, allowing scientists to run experiments via web browser. It is the closest direct competitor in the cloud lab automation-as-a-service category.
- Arctoris: Arctoris offers a fully automated, cloud-operated drug discovery platform combining robotics with AI-driven experiment design. It directly overlaps Strateos's cloud lab automation model for small molecule discovery.
- HighRes Biosolutions: HighRes Biosolutions provides integrated lab automation robotics and scheduling software for life sciences, used by pharma and biotech to build their own automated facilities. It is the primary alternative for customers choosing 'Build Your Lab' or 'Control Your Lab' over Strateos's cloud lab.
Broad incumbents
- Benchling: Benchling provides a cloud-based R&D platform spanning ELN, LIMS, and molecular biology workflows used by major pharma and biotech. It competes with Strateos's lab control software layer for informatics ownership, though Benchling does not operate physical robotic labs.
- Dotmatics: Dotmatics is an established scientific informatics platform (ELN, LIMS, data analysis) used broadly across pharma R&D. It overlaps with Strateos's lab control software and data management offerings as part of a wider portfolio rather than a specialized cloud lab.
- LabVantage Solutions: LabVantage is an established LIMS provider used in regulated pharmaceutical and biotech QC/research labs. It competes with Strateos's compliance and lab data management capabilities as a broad incumbent.
Emerging players
- Ginkgo Bioworks: Ginkgo operates a large-scale synthetic biology platform with significant automation and is a customer and partner-class comparable in lab automation-as-a-service for synbio. Overlap is partial: Ginkgo's automation is internal and serves its own programs, but the technology stack and target customers overlap with Strateos's synthetic biology offering.
- TetraScience: TetraScience provides a scientific data cloud and integration platform for R&D labs, ingesting instrument data from life sciences labs. It competes with Strateos's scientific data management and lab control software components, though without owning physical lab infrastructure.
- Scitara: Scitara provides a Scientific Integration Platform (iPaaS) for connecting lab instruments and informatics systems. It overlaps with Strateos's lab control and instrument integration capabilities at the software layer.
- Recursion Pharmaceuticals: Recursion operates an AI-driven drug discovery platform combining high-throughput wet-lab experimentation with machine learning. Its automation philosophy and target customers (AI pharma, biotech) overlap with Strateos's AI for Drug Discovery positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Transcriptic social profiles
Digital presenceTranscriptic financial estimates
Financial estimateRevenue estimate
Valuation estimate
Transcriptic leadership team
Management profileNumber of profiles
Profiles1 record
Transcriptic funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Transcriptic M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Transcriptic
What does Transcriptic do?
Strateos (formerly Transcriptic) operates a Cloud Lab Automation-as-a-Service Platform that lets scientists design, run, and analyze life sciences experiments remotely through a web browser by combining cloud-connected robotic laboratory equipment with intelligent lab control software and high-throughput experimentation. The company also provides Lab Build design-build services and on-premises Lab Control Software for organizations wanting to operate their own cloud-connected robotic facilities, alongside specialized drug discovery, synthetic biology, chemistry, and imaging solutions.
Is Transcriptic a public or private company?
Transcriptic is a private company. It is classified as venture growth investor backed and is currently operating.
When was Transcriptic founded?
Transcriptic was founded in 2012. It employs 11 to 50 people.
Where is Transcriptic based?
Transcriptic is headquartered in Menlo Park, United States, in the North America region.
How does Transcriptic make money?
Three revenue lines are on record. Cloud Lab Automation-as-a-Service is the primary driver. The others are lab Build Services and software Licensing.
Who are Transcriptic's main competitors?
Direct peers on record are Emerald Cloud Lab, Arctoris and HighRes Biosolutions. Broad incumbents are Benchling, Dotmatics and LabVantage Solutions. Emerging players are Ginkgo Bioworks, TetraScience, Scitara and Recursion Pharmaceuticals.
Does Transcriptic have an API?
Yes. Transcriptic offers a Developer Portal providing API documentation for its platform at https://developers.strateos.com/docs. The company maintains an Open Source presence at https://github.com/strateos/transcriptic and references Autoprotocol at https://autoprotocol.org/. Full API specifications, authentication methods, rate limits, and versioning details are not specified in the available source material. Developer documentation is at developers.strateos.com/docs.
What industry is Transcriptic in?
Transcriptic's product category is Cloud Lab Automation Platform. Its primary akta.pro industry code is HLAGAJAG, Lab Automation, Instrument Control & Workflow Orchestration Software, with a secondary code of HLAGAIAD, Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations). Its NAICS code is 513210 and its SIC code is 7372.